205470 — Humasis Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩224bn
- -KR₩19bn
- KR₩14bn
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Interim Report | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 21,605 | 22,995 | 195,191 | 318,695 | 242,991 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,168 | 8,901 | 36,962 | 9,212 | 23,911 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 25,771 | 42,557 | 294,575 | 372,796 | 277,799 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10,424 | 24,659 | 44,066 | 78,881 | 57,620 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 36,488 | 68,207 | 340,715 | 467,534 | 347,307 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15,472 | 9,672 | 135,473 | 118,125 | 59,763 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 21,244 | 19,523 | 138,709 | 120,800 | 59,981 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 15,244 | 48,684 | 202,006 | 346,734 | 287,327 |
Total Liabilities & Shareholders' Equity | 36,488 | 68,207 | 340,715 | 467,534 | 347,307 |
Total Common Shares Outstanding |